Ercros
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, … Read more
Ercros (ECR) - Net Assets
Latest net assets as of December 2025: €298.23 Million EUR
Based on the latest financial reports, Ercros (ECR) has net assets worth €298.23 Million EUR as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€694.30 Million) and total liabilities (€396.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €298.23 Million |
| % of Total Assets | 42.95% |
| Annual Growth Rate | -15.75% |
| 5-Year Change | -10.07% |
| 10-Year Change | 35.66% |
| Growth Volatility | 42.38 |
Ercros - Net Assets Trend (2000–2025)
This chart illustrates how Ercros's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ercros (2000–2025)
The table below shows the annual net assets of Ercros from 2000 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €298.23 Million | -12.58% |
| 2024-12-31 | €341.16 Million | -6.05% |
| 2023-12-31 | €363.12 Million | +0.67% |
| 2022-12-31 | €360.71 Million | +8.77% |
| 2021-12-31 | €331.61 Million | +16.68% |
| 2020-12-31 | €284.21 Million | -2.69% |
| 2019-12-31 | €292.08 Million | +7.12% |
| 2018-12-31 | €272.67 Million | +10.17% |
| 2017-12-31 | €247.49 Million | +12.58% |
| 2016-12-31 | €219.83 Million | +24.99% |
| 2015-12-31 | €175.88 Million | +4.57% |
| 2014-12-31 | €168.19 Million | -2.33% |
| 2013-12-31 | €172.21 Million | -0.95% |
| 2012-12-31 | €173.87 Million | -7.08% |
| 2011-12-31 | €187.11 Million | -2.66% |
| 2010-12-31 | €192.23 Million | -6.40% |
| 2009-12-31 | €205.38 Million | -20.15% |
| 2008-12-31 | €257.20 Million | -44.47% |
| 2007-12-31 | €463.14 Million | +28.66% |
| 2006-12-31 | €359.97 Million | +41.79% |
| 2005-12-31 | €253.87 Million | +167.06% |
| 2004-12-31 | €95.06 Million | -25.62% |
| 2003-12-31 | €127.80 Million | -12.22% |
| 2002-12-31 | €145.59 Million | +4.99% |
| 2001-12-31 | €138.67 Million | -99.36% |
| 2000-12-31 | €21.67 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ercros's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 118.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €27.43 Million | 9.55% |
| Other Comprehensive Income | €259.82 Million | 90.45% |
| Other Components | €53.59 Million | 18.65% |
| Total Equity | €287.25 Million | 100.00% |
Ercros Competitors by Market Cap
The table below lists competitors of Ercros ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Huifeng Agrochemical Co Ltd
SHE:002496
|
$265.01 Million |
|
Esker SA
OTCQX:ESKEF
|
$265.03 Million |
|
Wall Financial Corporation
PINK:WFICF
|
$265.12 Million |
|
Ares Commercial Real Estate
NYSE:ACRE
|
$265.18 Million |
|
Jinhong Fashion Group Co Ltd
SHG:603518
|
$264.90 Million |
|
Shaanxi Broadcast & TV Network Intermediary Group Co Ltd
SHG:600831
|
$264.87 Million |
|
China Resources Medical Holdings Company Limited
F:1PH
|
$264.86 Million |
|
Perpetual Equity Investment Company Ltd
AU:PIC
|
$264.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ercros's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 341,157,000 to 287,247,000, a change of -53,910,000 (-15.8%).
- Net loss of 53,585,000 reduced equity.
- Dividend payments of 325,000 reduced retained earnings.
- Other comprehensive income decreased equity by 65,567,000.
- Other factors increased equity by 65,567,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-53.59 Million | -18.65% |
| Dividends Paid | €325.00K | -0.11% |
| Other Comprehensive Income | €-65.57 Million | -22.83% |
| Other Changes | €65.57 Million | +22.83% |
| Total Change | €- | -15.80% |
Book Value vs Market Value Analysis
This analysis compares Ercros's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.08x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.63x to 1.08x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | €5.40 | €3.41 | x |
| 2004-12-31 | €4.03 | €3.41 | x |
| 2005-12-31 | €4.25 | €3.41 | x |
| 2006-12-31 | €4.95 | €3.41 | x |
| 2007-12-31 | €5.29 | €3.41 | x |
| 2008-12-31 | €2.92 | €3.41 | x |
| 2009-12-31 | €2.04 | €3.41 | x |
| 2010-12-31 | €1.91 | €3.41 | x |
| 2011-12-31 | €1.86 | €3.41 | x |
| 2012-12-31 | €1.73 | €3.41 | x |
| 2013-12-31 | €1.66 | €3.41 | x |
| 2014-12-31 | €1.53 | €3.41 | x |
| 2015-12-31 | €1.54 | €3.41 | x |
| 2016-12-31 | €1.93 | €3.41 | x |
| 2017-12-31 | €2.20 | €3.41 | x |
| 2018-12-31 | €2.50 | €3.41 | x |
| 2019-12-31 | €2.75 | €3.41 | x |
| 2020-12-31 | €2.77 | €3.41 | x |
| 2021-12-31 | €3.36 | €3.41 | x |
| 2022-12-31 | €3.83 | €3.41 | x |
| 2023-12-31 | €3.88 | €3.41 | x |
| 2024-12-31 | €3.73 | €3.41 | x |
| 2025-12-31 | €3.14 | €3.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ercros utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.65%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.55%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 2.42x
- Recent ROE (-18.65%) is above the historical average (-33.77%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -14.08% | -8.32% | 0.61x | 2.80x | €-30.43 Million |
| 2004 | -33.64% | -14.97% | 0.58x | 3.84x | €-41.10 Million |
| 2005 | 15.47% | 8.90% | 0.57x | 3.06x | €13.62 Million |
| 2006 | 1.36% | 0.67% | 0.72x | 2.82x | €-30.75 Million |
| 2007 | -710.14% | -387.85% | 0.89x | 2.06x | €-3.32 Billion |
| 2008 | -79.73% | -23.43% | 1.23x | 2.78x | €-228.48 Million |
| 2009 | -24.12% | -8.68% | 0.89x | 3.12x | €-69.99 Million |
| 2010 | -6.46% | -2.03% | 0.97x | 3.27x | €-31.56 Million |
| 2011 | -0.43% | -0.12% | 1.13x | 3.24x | €-19.48 Million |
| 2012 | -6.98% | -1.90% | 1.06x | 3.48x | €-29.52 Million |
| 2013 | -2.18% | -0.60% | 1.11x | 3.28x | €-20.97 Million |
| 2014 | -3.74% | -1.04% | 1.16x | 3.10x | €-23.11 Million |
| 2015 | 4.12% | 1.17% | 1.21x | 2.91x | €-10.35 Million |
| 2016 | 20.54% | 7.49% | 1.08x | 2.55x | €23.18 Million |
| 2017 | 18.01% | 6.50% | 1.14x | 2.42x | €19.83 Million |
| 2018 | 16.46% | 6.68% | 1.11x | 2.22x | €17.61 Million |
| 2019 | 10.63% | 4.63% | 1.02x | 2.25x | €1.83 Million |
| 2020 | 2.20% | 1.10% | 0.96x | 2.08x | €-22.16 Million |
| 2021 | 13.06% | 5.61% | 1.09x | 2.14x | €10.14 Million |
| 2022 | 17.46% | 6.31% | 1.34x | 2.07x | €26.92 Million |
| 2023 | 7.60% | 3.80% | 1.06x | 1.88x | €-8.73 Million |
| 2024 | -3.42% | -1.75% | 0.95x | 2.05x | €-45.77 Million |
| 2025 | -18.65% | -8.55% | 0.90x | 2.42x | €-82.31 Million |
Industry Comparison
This section compares Ercros's net assets metrics with peer companies in the Chemicals industry.
No peer company data available for comparison.